Clinical Trials Logo

Chronic Sinusitis clinical trials

View clinical trials related to Chronic Sinusitis.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06398899 Not yet recruiting - Clinical trials for Head and Neck Neoplasms

Sugammadex v.s. Neostigmine/Glycopyrrolate

Start date: May 1, 2024
Phase: N/A
Study type: Interventional

The aim of study is to clarify the role of sugammadex in head and neck surgery patients with a prior history of urinary retention, benign prostatic hypertrophy, or a history of prostate cancer, to prevent postoperative urinary retention. The main question it aims to answer are: - Anticholinergic agent interferes the postoperative urination - Sugammadex does not interfere postoperative urination Sugammadex can be recommended for these patients with high risk in postoperative urinary retention in the future.

NCT ID: NCT06070311 Not yet recruiting - Nasal Polyps Clinical Trials

Wound Healing After Endoscopic Sinus Surgery

Start date: October 2023
Phase: N/A
Study type: Interventional

This study aims to determine the effect of Thymoquinone (0.5%) and olive oil ointment on Wound healing after Endoscopic sinus surgery.

NCT ID: NCT05454163 Not yet recruiting - Pediatric Cancer Clinical Trials

Post-radiotherapy Rhinosinusitis in Children

PRRSC
Start date: October 2022
Phase:
Study type: Observational

Chronic rhinosinusitis (CRS) is a frequent complication of facial cancer treatment, mainly related to radiotherapy. However, while radiological involvement is frequent, clinical expression seems less important. Few studies have investigated the incidence of this condition in the pediatric population while its evolution seems to be very chronic even if a partial improvement may occur with time. Our objective is therefore to study the impact of CSR in children treated for cancer of the cervicofacial region, to evaluate its incidence and medium-term evolution in order to determine whether it is necessary to set up a specific follow-up in these patients. The clinical impact of CSR is assessed by a specific SNOT 22 questionnaire in children treated for a head-neck mesenchymal malignancy in comparison with a control population consisting of children treated for a mesenchymal malignancy of non-head-neck location.

NCT ID: NCT05369039 Not yet recruiting - Chronic Sinusitis Clinical Trials

Roflumilust in Chronic Rhinosinusitis With Nasal Polyposis.

Start date: June 2022
Phase: Phase 2
Study type: Interventional

The current study will be a pilot study for a randomized controlled trial conducted on 60 patients recruited from the outpatient clinic of the Otorhinolaryngology Department, Menoufia Faculty of Medicine after approval of the institutional review board and taking informed written consent from every patient before participation in the study. The patients of this study will be randomly and equally distributed among case and control groups to compare the effect of Roflumilust administration with the effect of systemic and local corticosteroids on patients with chronic rhinosinusitis with nasal polyposis

NCT ID: NCT05156801 Not yet recruiting - Chronic Sinusitis Clinical Trials

Efficacy of ArchSinus, NasoPore & Propel to Prevent Post-Surgical MT Lateralization and Improve Symptomatic Outcomes

Start date: March 2022
Phase: N/A
Study type: Interventional

This is a multi-center, randomized, single-blinded comparative 3-arm clinical study. This clinical study is designed to compare the efficacy of the ArchSinus stent to the Propel stent (Intersect ENT), and to NasoPore (Stryker) in preventing post-FESS middle turbinate lateralization 3 weeks, 6 weeks, 3 months and 12 months post FESS.

NCT ID: NCT04374448 Not yet recruiting - Chronic Sinusitis Clinical Trials

Utility of Indocyanine Green Fluorescence in Endoscopic Sinonasal and Skull Base Surgery

NIRFICG
Start date: January 1, 2023
Phase: N/A
Study type: Interventional

The endoscope is a device placed into the nasal cavity to remove chronic sinus disease or tumor or create access into the skullbase for extensive tumor removal. Indocyanine Green (ICG) is a dye that is injected through an intravenous site and is used to light up vasculature and margins of a tumor during surgery. This helps avoid damage to important vasculature and obtain clear margins during surgery. This study aims to further assess the utility of ICG when operating within the nasal cavity or skullbase.

NCT ID: NCT03903432 Not yet recruiting - Chronic Sinusitis Clinical Trials

The Feasibility of Using MRI During ESS

ESS
Start date: May 15, 2019
Phase: N/A
Study type: Interventional

Before performing endoscopic sinus surgery (ESS-Endoscopic Sinus Surgery), every candidate for surgery is referred to perform a sinus CT scan of the sinuses. Because of the complicated anatomy of the sinuses and their proximity to vital organs such as the brain, eye, and carotid artery, the surgeon use the CT imaging during surgery to adjust the anatomy and to avoid complications such as blindness, brain damage and massive bleeding (0.3%). Sometimes the CT is integrated into a navigation system, although there is no evidence that the use of navigation systems reduces the rate of complications. The aim of our study is to examine whether ESS can be performed in chronic sinusitis patients using MRI, with CT being used as a backup only.

NCT ID: NCT00852410 Not yet recruiting - Chronic Sinusitis Clinical Trials

The Hemostatic and Hemodynamic Effects of Adrenaline During Endoscopic Sinus Surgery

Start date: March 2009
Phase: Phase 3
Study type: Interventional

Obtaining adequate hemostasis is crucial during endoscopic sinus surgery. Submucosal injection of local anaesthetic containing adrenaline has frequently been used to improve surgical milieu. However, injection of adrenaline has potential side effects including tachycardia, hypertension as well as inducing arrhythmia. The aim of this randomized clinical trial is to assess the hemodynamic and hemostatic effects of two different concentrations of adrenaline in local anaesthetic used during endoscopic sinus surgery.